Page 26 - Wyss Institute For Biologically Inspired Engineering News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wyss institute for biologically inspired engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wyss Institute For Biologically Inspired Engineering Today - Breaking & Trending Today

Obatala Sciences, Harvard partner on human fat tissue study


Obatala Sciences, Harvard partner on human fat tissue study
New Orleans-based biotechnology firm Obatala Sciences has been granted an exclusive license from Harvard University to commercialize innovations that enable the study of human fat tissue in vitro.
The licensed Harvard technology, an adipose-on-a-chip, provides a method of obtaining adult-size fat tissue cells for study in vitro and enables the testing of weight loss and cancer-targeting therapeutics without the need for testing in animals, a news release said. It provides a more accurate and dynamic model of human tissue in its diseased state compared to traditional 2-dimensional culture, the release said. ....

United States , New Orleans , Wyss Institute For Biologically Inspired Engineering , Obatala Sciences , Harvard University , Disease Biophysics Group At Harvard , Harvard Johna Paulson School Of Engineering , New Orleans Based , Disease Biophysics Group , Kit Parker , Tarr Family Professor , Applied Physics , Harvard John , Applied Sciences , Associate Faculty , Wyss Institute , Biologically Inspired , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஆர்லீயந்ஸ் , ஹார்வர்ட் பல்கலைக்கழகம் , ஹார்வர்ட் ஜொன்னா பால்சன் பள்ளி ஆஃப் பொறியியல் , புதியது ஆர்லீயந்ஸ் அடிப்படையிலானது , நோய் உயிர் இயற்பியல் குழு , கிட் பார்க்கர் , தார் குடும்பம் ப்ரொஃபெஸர் , பயன்படுத்தப்பட்டது இயற்பியல் ,

Researchers uncover mechanism related to severe post-COVID-19 disease in children


 E-Mail
BOSTON A multidisciplinary team from MassGeneral Hospital for Children (MGHfC), Brigham and Women s Hospital and other institutions have identified the mechanism of how an extremely rare but serious post-COVID-19 complication develops in children and adolescents. Led by MGHfC pediatric pulmonologist Lael Yonker, MD, researchers determined that viral particles remaining in the gut long after an initial COVID-19 infection can travel into the bloodstream, instigating the condition called Multisystem Inflammatory Syndrome in Children (MIS-C).
The syndrome can occur several weeks after an initial infection; symptoms include high fever, abdominal pain, vomiting, diarrhea, rash and extreme fatigue. The hyperinflammatory response and cytokine storm seen in MIS-C can lead to extensive damage in the heart, liver and other organs. ....

United States , North Carolina , Amos Hostetter , Alessio Fasano , Los Angeles , David Walt , Lael Yonker , Moshe Arditi , National Institute Of Diabetes , Us Centers For Disease , Ragon Institute , European Biomedical Research Institute Of Salerno , Melinda Gates Foundation , University Of Maryland School Medicine , Blood Institute , National Heart , Wyss Institute For Biologically Inspired Engineering , Chieck Foundation , Mghfc Division Of Pediatric Gastroenterology , Sinai Medical Center , National Institutes Of Health , Immunological Diseases Research Center At Cedars , Drug Administration , Department Of Pediatrics , Massgeneral Hospital , Multisystem Inflammatory Syndrome ,

Auravax Therapeutics Announces Formation of Scientific Advisory Board Chaired by George M. Church, PhD


Share this article
Share this article
HOUSTON, May 25, 2021 /PRNewswire/  AuraVax Therapeutics, Inc. (Auravax), a biotech company developing novel intranasal therapeutics and vaccines to help patients defeat debilitating respiratory diseases, including COVID-19, today announced the formation of its inaugural Scientific Advisory Board (SAB), consisting of leading experts in the fields of biology, vaccines and intranasal drug delivery. The SAB will guide and advise the company in its ongoing development of proprietary therapeutics and vaccines for respiratory diseases.
The SAB is chaired by George M. Church, Ph.D. and includes Stephen Albert Johnston from Calviri, Inc and Mei X. Wu, Ph.D. from Massachusetts General Hospital/Harvard Medical School. ....

United States , Massachusetts Institute Of Technology , Harvard University , Georgem Church , Stephen Albert Johnston , Navin Varadarajan , Matthewj Meyer , George Church , Meix Wu , Franklin Institute Bower Award For Achievement , Principal Investigator Of The Center , National Academy Of Sciences , Professor Of Health Sciences , Wyss Institute , Auravax Therapeutics Inc , Wellman Center , Calviri Inc , Wyss Institute For Biologically Inspired Engineering , Hospital Harvard Medical School , Biodesign Institute , Harvard Medical School , Lipper Center , Department Of Dermatology , Auravax Therapeutics , Scientific Advisory Board , Massachusetts General ,